Taiwanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Formosa Pharmaceuticals

Market Cap: NT$3.4b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

Maxigen Biotech

Market Cap: NT$3.5b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

BIONET Therapeutics

Market Cap: NT$3.0b

A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.

Orient Pharma

Market Cap: NT$6.7b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

Synmosa Biopharma

Market Cap: NT$13.2b

A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.

Savior Lifetec

Market Cap: NT$5.1b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

TCM Biotech International

Market Cap: NT$3.1b

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.

Shine-On BioMedicalLtd

Market Cap: NT$3.3b

Research, develops, and manufactures anti-cancer related drug products.

CHO Pharma

Market Cap: NT$9.4b

Engages in research and development of biotechnology in Taiwan.

Eusol BiotechLtd

Market Cap: NT$808.3m

Focuses on research and development of new biotech drugs for sleep disorders.

Holy Stone Healthcare

Market Cap: NT$1.2b

Develops and sells hyaluronic acid related therapeutic products.

Advagene Biopharma

Market Cap: NT$1.1b

Engages in the research and development of vaccine technology and related products in Taiwan.

PharmaEngine

Market Cap: NT$12.2b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

PhytoHealth

Market Cap: NT$2.5b

Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.

HeXun Biosciences

Market Cap: NT$3.6b

Engages in the research and development of stem cell and treatments in Taiwan.

EirGenix

Market Cap: NT$18.9b

Operates as a contract development and manufacturing company in Taiwan and internationally.

ScinoPharm Taiwan

Market Cap: NT$14.1b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

Ever Supreme Bio Technology

Market Cap: NT$12.9b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells.

Sinew Pharma

Market Cap: NT$3.1b

A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

TaiwanJ Pharmaceuticals

Market Cap: NT$632.2m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

Alar Pharmaceuticals

Market Cap: NT$8.0b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Oneness Biotech

Market Cap: NT$28.3b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.0b

Standard Chemical & Pharmaceutical Co. Ltd.

BRIM Biotechnology

Market Cap: NT$3.0b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.

PharmaEssentia

Market Cap: NT$164.9b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Senhwa Biosciences

Market Cap: NT$2.9b

A drug development company, engages in the development of new drugs and targeted agents.

Pharmosa Biopharm

Market Cap: NT$5.8b

A biotechnology company, focuses on developing drugs in Taiwan.

GlycoNex Incorporation

Market Cap: NT$1.8b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.

Medigen Vaccine Biologics

Market Cap: NT$13.2b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

UnicoCell Biomed

Market Cap: NT$3.9b

Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

TSH Biopharm

Market Cap: NT$1.8b

Develops and markets pharmaceutical products in Taiwan and Asia.

DV Biomed

Market Cap: NT$1.3b

Manufactures and sells medical-grade skin care products in Taiwan and China.

SynCore BiotechnologyLtd

Market Cap: NT$951.2m

Engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan.

TTY Biopharm

Market Cap: NT$17.4b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

Abnova (Taiwan)

Market Cap: NT$1.4b

Manufactures and sells various recombinant proteins and antibodies.

Lumosa Therapeutics

Market Cap: NT$25.9b

A clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan, Asia, the Americas, and Europe.